True Light Psychotherapy
  • Home
  • About Me
  • Psychotherapy Services
    • About Expressive Arts
    • About Sandtray Therapy
    • Ketamine-Assisted Therapy (KAP)
    • About Guided Imagery
    • About Group Work
  • Groups
  • Rates
  • Contact Me

Ketamine-Assisted Therapy (KAP)

Picture


​
WHAT IS KETAMINE?

I offer a therapeutic modality called Ketamine-Assisted Psychotherapy (KAP), the use of ketamine as a complement to psychotherapy. The medicine Ketamine has been shown to be a safe and potent treatment for depression, anxiety, post-traumatic stress disorder and other mental health conditions.  I deliver KAP in my practice in partnership with an organization called Journey Clinical, which has a specialized medical team that determines eligibility for KAP, prescribes the ketamine, and supports us in monitoring outcomes.
 

​
Ketamine is considered a psycholytic, dissociative medicine which creates a dream-like state in which the ego structures are relaxed and the client has greater access to insights and self-understanding. Ketamine-Assisted Psychotherapy (KAP) is a holistic modality in which ketamine is used with psychotherapy to help eligible patients experience more frequent breakthroughs and sustained improvement in symptoms. I take on the psychotherapy portion of the experience, while Journey Clinical’s medical team supports you on all medical aspects. This includes determining eligibility, developing a custom treatment plan, prescribing the medicine and monitoring outcomes.
​

To learn more, please contact me or visit www.journeyclinical.com 
​
“Depending on dose, ketamine promotes a time-out from ordinary, usual mind, relief from negativity, and an openness to the expansiveness of mind with access to self in the larger sense. These effects enhance a patient’s ability to engage in meaningful psychotherapy during and after administration. Ketamine is potent for respite, analysis, and meditative presence, and potent for recovery from depression and the lingering effects of trauma.”
 from J. Dore, et al., 2019, Journal of Psychoactive Drugs. 2019, April-June "Ketamine Assisted Psychotherapy: Patient Demographics, Clinical Data and Outcomes" 
For more research-based information go to: pubmed.ncbi.nlm.nih.gov/30917760/


​

​